Professor, Internal Medicine, University of Utah School of Medicine
Nephrology
Dr. Fuad S. Shihab, MD
|
|
Give Review
Dr. Fuad S. Shihab practices Nephrology. He received awards:"Regional Top Doctor" and "Fellow (ASNF)". Doctor Fuad S. Shihab, MD is a published doctor. He published 76 publications, including: 'Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after r...' Fuad S. Shihab, MD is registered with Medicare and accepts Medicare payments.
Publications
- Cardiovascular Risk Assessment and Management in PreRenal Transplantation Candidates.
- Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil With tacrolimus after renal transplantation.
- Transfer of Peanut IgE Sensitization after Combined Pancreas-Kidney Transplant.
- Focus on mTOR inhibitors and tacrolimus in Renal transplantation: Pharmacokinetics, exposure-response relationships, and clinical outcomes.
- Tacrolimus exposure in the real world: An analysis from the Mycophenolic acid Observational Renal transplant study.
- Outcomes in Ethnic Minority Renal Transplant Recipients Receiving Everolimus versus Mycophenolate: Comparative Risk Assessment Results From a Pooled Analysis.
- Long-term outcomes in African American Kidney transplant recipients under contemporary immunosuppression: a four-yr analysis of the Mycophenolic acid Observational REn...
- Acute Rejection Characteristics From a Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Early Corticosteroid Withdrawal.
- Outcomes in african american Kidney transplant patients receiving tacrolimus and mycophenolic Acid immunosuppression.
- Randomized Trial of Everolimus-Facilitated Calcineurin Inhibitor Minimization Over 24 Months in Renal Transplantation.
- Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Trans...
- Association of clinical events with everolimus exposure in Kidney transplant patients receiving reduced cyclosporine.
- Effect of corticosteroid Withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study.
- Effect of Donor Kidney Volume on Recipient Outcome: Does the "Dose" Matter?
- Low-dose fluconazole prophylaxis in Kidney transplant recipients receiving tacrolimus.
- No occurrence of de novo HLA antibodies in patients With early corticosteroid Withdrawal in a 5-year prospective randomized study.
- Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic Kidney transplantation.
- Do we have a pill for Renal fibrosis?
- Role of maintenance immunosuppressive regimen in Kidney transplant outcome.
- Effect of pirfenidone on apoptosis-regulatory genes in Chronic cyclosporine nephrotoxicity.
- Sirolimus increases transforming growth factor-beta1 expression and potentiates Chronic cyclosporine nephrotoxicity.
- Combination therapy with sirolimus and mycophenolate mofetil: effects on the Kidney and on transforming growth factor-beta1.
- Lack of economic benefit With basiliximab induction in living related donor adult renal transplant recipients.
- Nitric oxide modulates vascular endothelial growth factor and receptors in Chronic cyclosporine nephrotoxicity.
- Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity.
- A retrospective analysis of ezetimibe treatment in Renal transplant recipients.
- Successful treatment of recurrent Henoch-Schönlein purpura in a renal allograft With plasmapheresis.
- Surgical treatment of carcinoma of the abdominal colon.
- Intraperitoneal administration of an I125 labelled monoclonal antibody for localization of human colorectal cancer in the nude mouse.
- Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience.
- Cytokine-related encephalopathy induced by OKT3: incidence and predisposing factors.
- A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric Renal transplantation.
- Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of Acute graft rejection episodes after r...
- Role of socioeconomic status in Kidney transplant outcome.
- The association between recipient alcohol dependency and long-term graft and recipient survival.
- A population-based assessment of the familial component of Acute kidney allograft rejection.
- The role of the economic environment in Kidney transplant outcomes.
- RIFLE criteria accurately identifies renal dysfunction and renal Failure in elderly patients with upper gastrointestinal hemorrhage: a pilot study.
- A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroi...
- The impact of recipient history of cardiovascular disease on Kidney transplant outcome.
- A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo Renal transplant recipients.
- The impact of employment status on recipient and Renal allograft survival.
- Factors associated with nonadherence to medication in Kidney transplant recipients.
- Urine TGF- beta1 assay validation: spinning down urine samples could diminish TGF-beta1 signal.
- Cytomegalovirus incidence between everolimus versus mycophenolate in de novo Renal transplants: pooled analysis of three clinical trials.
- Preconditioning: from experimental findings to novel therapies in Acute kidney injury.
- Mechanism of fibrosis in experimental tacrolimus nephrotoxicity.
- Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine Nephropathy.
- Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental Chronic cyclosporine nephropathy.
- Identification of promoter activity and differential expression of transcripts encoding the murine stromelysin-1 gene in Renal cells.
- Cyclosporine Nephropathy: pathophysiology and clinical impact.
- Expression of TGF-beta 1 and matrix proteins is elevated in rats with Chronic rejection.
- Hyperadrenergic state following Acute withdrawal from clonidine used at supratherapeutic doses.
- Role of transforming growth factor-beta 1 in experimental Chronic cyclosporine nephropathy.
- Encephalopathy following the use of OKT3 in Renal allograft transplantation.
- Transforming growth factor-beta and matrix protein expression in Acute and chronic rejection of human renal allografts.
- Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a Renal allograft recipient.
- Renin-angiotensin system in Chronic renal allograft dysfunction.
- Expression of vascular endothelial growth factor and its receptors Flt-1 and KDR/Flk-1 in Chronic cyclosporine nephrotoxicity.
- De novo fibrillary glomerulopathy in the renal allograft of a patient With systemic lupus erythematosus.
- Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in Chronic cyclosporine nephrotoxicity.
- Expression of apoptosis regulatory genes in Chronic cyclosporine nephrotoxicity favors apoptosis.
- Recurrent lupus nephritis in the second allograft of a patient With systemic lupus erythematosus.
- De novo C1q nephropathy in the renal allograft of a Kidney pancreas transplant recipient: BK virus-induced nephropathy?
- Mycophenolate mofetil ameliorates arteriolopathy and decreases transforming growth factor-beta1 in Chronic cyclosporine nephrotoxicity.
- Effect of cyclosporine and sirolimus on the expression of connective tissue growth factor in rat experimental Chronic nephrotoxicity.
- The association between length of post-Kidney transplant hospitalization and long-term graft and recipient survival.
- Role of cellular cholesterol in pharmacologic preconditioning with cyclosporine in experimental Kidney transplantation.
- Report of the first international liver transplantation society expert panel consensus conference on Renal insufficiency in liver transplantation.
- Post-transplant increased levels of serum sCD30 is a marker for prediction of Kidney allograft loss in a 5-year prospective study.
- Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in Chronic cyclosporine nephrotoxicity.
- A retrospective assessment of pre-treatment variables on the response to darbepoetin alfa after Renal transplantation.
- Optimizing tacrolimus therapy in the maintenance of Renal allografts: 12-month results.
- Factors affecting Kidney-transplant outcome in recipients with lupus nephritis.
- Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft Failure: 60-month results of the CRAF Study.
Schools
American University Of Beirut Faculty Of Medicine
MD Genl Hospital
Hospital Of The University Of Pennsylvania
Oregon Health and Science University
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (ASNF)
Education
-
University of Pennsylvania Health System -
American University of Beirut Faculty of Medicine
Hospital
-
University of Utah Health Care - Hospital and Clinics
Drug Facts
| NPI NUMBER | 1700976321 | |
| NPPES Provider LastName | SHIHAB | |
| NPPES Provider FirstName | FUAD | |
| NPPES Provider ZIPCode | 841320001 | |
| NPPES Provider State | UT | |
| Specialty Description | Nephrology | |
| Total Claim Count | 1248.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700976321 |
| Last Name Of The Provider | SHIHAB |
| First Name Of The Provider | FUAD |
| View All |
Similar Doctors
|
|
Dr. Donald R. Morris, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vijaykumar Lingegowda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin C. Gregory, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kalani L. Raphael, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward B. Clark, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christof Westenfelder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Owolabi Ogunneye, MD |
|
|
Dr. Arsalan N. Habid, MD |
|
|
Dr. Andrew S. Weiss, MD |
|
|
Tahir A. Zaman |
|
|
Dr. Tahir A. Zaman, MD |
|
|
Dr. Michael S. Holland, MD |
|
|
Dr. Robert Murithi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harry O. Senekjian, MD
This Doctor is OpenDoctor Recommended.
|